Enjaymo
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Enjaymo, covering 2022-02-04 to 2025-08-01. Get the full timeline:
Most recent: EMA Authorised: Enjaymo (sutimlimab) — Recordati Rare Diseases
5 regulatory and trial events tracked for Enjaymo, covering 2022-02-04 to 2025-08-01. Get the full timeline:
Most recent: EMA Authorised: Enjaymo (sutimlimab) — Recordati Rare Diseases